Tag: life sciences
-
Chip Device to Test Gut Infections on Space Station
A device with human intestine tissue and cells will be launched into space to test effects of weightlessness on immune functions and bacterial infections in the gastrointestinal tract.
-
Virtual Reality Illness Fix in Development
A computer science and engineering team in Texas is developing a technical solution for virtual reality experiences that can make some users physically ill, with symptoms like seasickness.
-
Bluetooth Data Added to Ingestible Capsules
Engineers created a sensor device, which in tests with pigs can be packed into a capsule, swallowed, and communicate wirelessly for weeks with Bluetooth protocols.
-
Companies to Analyze 40,000 Protein Samples
A partnership between genomic analysis company deCode Genetics and proteomics enterprise SomaLogic plans to analyze protein activity in 40,000 human samples.
-
Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal
Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain.
-
Nanotech Gene Therapy Company Raises $8.5M in Seed Funds
A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round.
-
FDA Clears Mobile App for Opioid Use Disorder
The Food and Drug Administration authorized a mobile app, when prescribed by clinicians for patients with opioid use disorder in outpatient treatment programs.
-
Patent Set for Long-Term Drug Capsules
Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities.
-
RNA Biotech Raises $604M in IPO
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million.
-
Post-Surgical Opioid Prescriptions Safely Cut
A cancer center reduced its opioid pain prescriptions for surgery for a year, without patients reporting more pain, complications, or requests for more pills.